SV Stumble - SigVie Trial Misses on OS With Signs of Benefit for Future Trials

研报英文原文证据摘录

SV Stumble - SigVie Trial Misses on OS With Signs of Benefit for Future Trials

o Singapore Residents: This report is intended for general circulation and does not and is not intended to constitute the provision of financial

advisory services, whether directly or indirectly, to persons in Singapore. You should seek advice from a financial adviser regarding the suitability

of the investment products, taking into account your specific investment objectives, financial situation or particular needs before you make a

commitment to purchase the investment product. This report has not been registered as a prospectus with the Monetary Authority of Singapore.

Accordingly, it should not be circulated or distributed, nor may the securities described herein be offered or sold, or be made the subject of

an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (a) to an institutional investor or a

relevant person as defined in and pursuant to and in accordance with the conditions of the relevant provisions of the Securities and Futures Act

of Singapore or (b) otherwise pursuant to and in accordance with the conditions of, any other applicable provision of the SFA.

To Israeli residents: BMO Capital Markets is not licensed under the Israeli Law for the Regulation of Investment Advice, Investment Marketing

and Portfolio Management of 1995 (the "Advice Law") nor does it carry insurance as required thereunder. This document is to be distributed

solely to persons that are qualified clients (as defined under the Advice Law) and qualified investors under the Israeli Securities Law of 1968.

This document represents the analysis of the analyst but there is no assurance that any assumption or estimation will materialize.